GlassScriptPhysician profile
Alfred B Brady, JR.
NPI 1841293909
$8,285.46
in general payments reported to CMS, 2019-2025
20 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $61.32 · 2021: $1,436 · 2022: $5,742 · 2023: $328 · 2024: $107 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $6,883.33 | 2021-2022 | |
| Abbott Laboratories | $180.11 | 2021-2024 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $167.07 | 2019-2025 | Camzyos, Eliquis |
| Inspire Medical Systems, INC. | $141.69 | 2023-2025 | Inspire |
| Merck Sharp & Dohme LLC | $139.67 | 2023-2025 | Verquvo, Winrevair |
| Akcea Therapeutics, INC. | $119.00 | 2019 | |
| Pfizer INC. | $112.46 | 2019-2025 | |
| Boston Scientific Corporation | $110.21 | 2020-2025 | General - Ep |
| Alnylam Pharmaceuticals INC. | $101.73 | 2025 | Amvuttra |
| Janssen Pharmaceuticals, INC | $69.68 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $51.64 | 2019-2022 | |
| Tactile Systems Technology INC | $42.11 | 2020-2023 | Flexitouch Plus, Entre Plus |
| Sanofi-Aventis U.S. LLC | $32.84 | 2021 | |
| Innovation Technologies INC | $28.44 | 2025 | Irrisept |
| Kestra Medical Technology Services, INC. | $23.26 | 2025 | Assure Wcd |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $20.10 | 2023 | Inpefa |
| Amgen INC. | $17.59 | 2021 | |
| Avinger INC. | $15.92 | 2020 | |
| Medtronic Vascular, INC. | $14.52 | 2020 | |
| Irhythm Technologies, INC. | $14.09 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfred Brady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.